Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Kidney International. Supplement
|
July 21, 1999
Endothelial function in proteinuric renal disease
J A Joles, E S Stroes, T J Rabelink
Blood Purification
|
January 1, 1996
Mechanisms of cardiovascular injury in renal disease
T J Rabelink, E S Stroes, H A Koomans
Handbook of Experimental Pharmacology
|
December 20, 2014
ApoA-I mimetics
R M Stoekenbroek, E S Stroes, G K Hovingh
European Journal of Clinical Investigation
|
November 21, 1998
Redox state and health: a persisting challenge
E S Stroes, T J Rabelink, E E Van Faassen
Cardiovascular Research
|
December 23, 1998
Endothelin blockers and renal protection: a new strategy to prevent end-organ damage in cardiovascular disease?
T J Rabelink, E S Stroes, K P Bouter, et al.
Kidney International
|
December 1, 1996
Endothelin in renal pathophysiology: from experimental to therapeutic application
T J Rabelink, K A Kaasjager, E S Stroes, et al.
Lancet (London, England)
|
August 19, 1995
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication
E S Stroes, H A Koomans, T W de Bruin, et al.
Journal of Cardiovascular Pharmacology
|
March 9, 1999
Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo
L T Dijkhorst-Oei, E S Stroes, H A Koomans, et al.
Journal of Cardiovascular Pharmacology
|
January 12, 1999
Oxygen radical stress in vascular disease: the role of endothelial nitric oxide synthase
E S Stroes, E E van Faassen, G J van Londen, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 20, 1991
[When can desensitization with bee and wasp venom be stopped?]
H D Oei, E S Stroes, W P Beukema, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Kidney International. Supplement
|
July 21, 1999
Endothelial function in proteinuric renal disease
J A Joles, E S Stroes, T J Rabelink
Blood Purification
|
January 1, 1996
Mechanisms of cardiovascular injury in renal disease
T J Rabelink, E S Stroes, H A Koomans
Handbook of Experimental Pharmacology
|
December 20, 2014
ApoA-I mimetics
R M Stoekenbroek, E S Stroes, G K Hovingh
European Journal of Clinical Investigation
|
November 21, 1998
Redox state and health: a persisting challenge
E S Stroes, T J Rabelink, E E Van Faassen
Cardiovascular Research
|
December 23, 1998
Endothelin blockers and renal protection: a new strategy to prevent end-organ damage in cardiovascular disease?
T J Rabelink, E S Stroes, K P Bouter, et al.
Kidney International
|
December 1, 1996
Endothelin in renal pathophysiology: from experimental to therapeutic application
T J Rabelink, K A Kaasjager, E S Stroes, et al.
Lancet (London, England)
|
August 19, 1995
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication
E S Stroes, H A Koomans, T W de Bruin, et al.
Journal of Cardiovascular Pharmacology
|
March 9, 1999
Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo
L T Dijkhorst-Oei, E S Stroes, H A Koomans, et al.
Journal of Cardiovascular Pharmacology
|
January 12, 1999
Oxygen radical stress in vascular disease: the role of endothelial nitric oxide synthase
E S Stroes, E E van Faassen, G J van Londen, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 20, 1991
[When can desensitization with bee and wasp venom be stopped?]
H D Oei, E S Stroes, W P Beukema, et al.
Page
of 4